GRFS (Grifols) Gross Margin % : 36.88% (As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Grifols Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Grifols's Gross Profit for the three months ended in Jun. 2024 was $722 Mil. Grifols's Revenue for the three months ended in Jun. 2024 was $1,957 Mil. Therefore, Grifols's Gross Margin % for the quarter that ended in Jun. 2024 was 36.88%.

Warning Sign:

Grifols SA gross margin has been in long-term decline. The average rate of decline per year is -4.7%.

The historical rank and industry rank for Grifols's Gross Margin % or its related term are showing as below:

GRFS' s Gross Margin % Range Over the Past 10 Years
Min: 36.8 Med: 45.8 Max: 50.64
Current: 38.42

During the past 13 years, the highest Gross Margin % of Grifols was 50.64%. The lowest was 36.80%. And the median was 45.80%.

GRFS's Gross Margin % is ranked worse than
65.42% of 966 companies
in the Drug Manufacturers industry
Industry Median: 47.005 vs GRFS: 38.42

Grifols had a gross margin of 36.88% for the quarter that ended in Jun. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Grifols was -4.70% per year.

Grifols Gross Margin % Historical Data

The historical data trend for Grifols's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Gross Margin % Chart

Grifols Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

Get a 7-Day Free Trial

45.92

42.23

39.78

36.80

37.84

Grifols Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Jun24
Gross Margin %	Get a 7-Day Free Trial															34.98	36.53	39.55	38.98	36.88

Competitive Comparison of Grifols's Gross Margin %

For the Drug Manufacturers - General subindustry, Grifols's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grifols's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Grifols's Gross Margin % falls into.

Grifols Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Grifols's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	2720.4	/	7188.634
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(7188.634 - 4468.273)	/	7188.634
	=	37.84 %

Grifols's Gross Margin for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )	=	Gross Profit (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	721.7	/	1956.843
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(1956.843 - 1235.161)	/	1956.843
	=	36.88 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Grifols (NAS:GRFS) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Grifols had a gross margin of 36.88% for the quarter that ended in Jun. 2024 => Competition eroding margins

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Grifols Gross Margin % Related Terms

Thank you for viewing the detailed overview of Grifols's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Grifols Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (NAS:GRFS) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

GIKLY:USA GIFOF:USA GIFLF:USA GRFe:UK GRFPe:UK 0RDV:UK 0RDU:UK GRF.P:Spain GRF:Spain G0FB:Germany OZTA:Germany OZTA:Germany G0FB:Germany GRF:Austria

Address

Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174

Website

https://www.grifols.com

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.